Abbott may look to expand the geographic footprint of its medical device business, CFO Thomas Freyman says.
Abbott (NYSE:ABT) may look to expand the geographic footprint of its medical device footprint and has no plans to shed its branded generic pharmaceuticals arm, CFO Thomas Freyman said yesterday.
from MassDevice - FDA and Medical device business news and jobs for the medical device industry http://ift.tt/1fUoBkX
Cap comentari:
Publica un comentari a l'entrada